25. February 2016
PEPperPRINT and Zedira commonly present the new PEPperCHIP® Transglutaminase Microarray!
The PEPperCHIP® Transglutaminase Microarray is based on 6 transglutaminase variants (hFXIII, hTG1, hTG2, hTG3, hTG4 and hTG6) and can be used for
Document
Curious about your antibody or anti-serum?
PEPperPRINT and Zedira commonly present the new PEPperCHIP® Transglutaminase Microarray!
The PEPperCHIP® Transglutaminase Microarray is based on 6 transglutaminase variants (hFXIII, hTG1, hTG2, hTG3, hTG4 and hTG6) and can be used for
 |
high resolution epitope mapping of anti-transglutaminase antibodies |
|
antibody specificity analysis with 6 different transglutaminase antigens |
|
serum antibody screening for anti-transglutaminase antibodies |
|
isotype-specific IgG and IgA profiling from serum and plasma |
| |
correlation of anti-transglutaminase antibody responses with pathogenesis |
| Art. No. | Name | Unit | Price | |||
| P111 | PEPperCHIP® Transglutaminase Microarray (Standard microarray) |
1 Chip | 425 € | |||
| P112 | PEPperCHIP® Custom Transglutaminase Microarray (Customized transglutaminase microarray layout) |
1 Chip | 895 € | |||
| P113 | PEPperCHIP® Transglutaminase Microarray Service (Full service IgG and IgA analysis of one sample) |
1 Sample | 695 € |
| |
Learn more about PEPperCHIP® Laser Printing Platform or |
|
Learn more about PEPperCHIP® Epitope Mapping |
Document
Reversibly acting transglutaminase 2 inhibitors: drug candidates for the treatment of fibrosis
Press release: Zedira announces ISO 9001:2015 certification
Zedira communication: Joint poster presentation on “Feasibility of a new automated FXIII activity assay”
Artikel in DZG Aktuell 01/2019 über die klinische Wirksamkeitsstudie unseres potentiellen Zöliakie Medikaments (deutsch)
Preview: Catalogue Editorial 2019
Design of Oral FXIIIa Blockers as Safer Anticoagulants – Mission Impossible?
Microbial transglutaminase (MTG) enables efficient and site-specific conjugation to native antibodies without the need of antibody engineering
Tridegin as FXIIIa inhibitor
Microbial transglutaminase: from discovery to market
Tissue transglutaminase inhibitors
Tissue transglutaminase in Alzheimer’s Disease
Factor XIIIa: novel target for anticoagulation?
Microbial transglutaminase for site-specific protein conjugation
Transglutaminase antibodies in ataxia